Mary Chapman, features writer —

Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.

Articles by Mary Chapman

Common Misdiagnoses of AADC Deficiency

Only about 100 cases of aromatic l-amino acid decarboxylase (AADC) deficiency are reported in scientific literature globally. This is partly because some individuals are wrongly diagnosed with cerebral palsy or other neurological conditions. Here are some reasons for the misdiagnoses that commonly accompany AADC deficiency. What is…

About the AADC Diagnostic Testing Program

There are only about 100 reported cases of aromatic l-amino acid decarboxylase (AADC) deficiency globally. That’s partly because some patients do not receive the right diagnosis and doctors think they have cerebral palsy or another neurological condition. To drive the identification of more AADC patients, and to raise…

AADC Community Invited to Submit Works to 2020 Rare Artist Contest

To raise awareness of the rare disease community and celebrate the creativity of its members, the EveryLife Foundation for Rare Diseases is seeking submissions to the 2020 Rare Artist contest. Established in 2010, the contest is open internationally to patients, caregivers, physicians, friends, or anyone else who…

What is the iNTD and Its Patient Registry?

If your child has aromatic l-amino acid decarboxylase (AADC) deficiency, you may want to consider participating in the patient registry of the International Working Group on Neurotransmitter Related Disorders (iNTD). The group’s aim is to foster global exchange of clinical data, with the ultimate goal of improving…

Newborn Screening and AADC Deficiency

Newborn screening for aromatic L-amino acid decarboxylase (AADC) deficiency has been studied, but has not yet been not been implemented. This is due partly to a lack of availability and standardization of noninvasive testing methods. Still, innovative treatment options, particularly gene therapy, have underscored the importance…